PHASE I STUDY OF TAXOTERE IN PATIENTS WITH ADVANCED MALIGNANCIES AND VARYING DEGREES OF LIVER DYSFUNCTION
Phase of Trial: Phase I
Latest Information Update: 28 Jul 2016
At a glance
- Drugs Docetaxel (Primary)
- Indications Breast cancer; Head and neck cancer; Non-small cell lung cancer; Ovarian cancer; Solid tumours
- Focus Adverse reactions
- 19 Jan 2010 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 07 Sep 2006 Status change
- 10 Sep 2005 New trial record.